DICP OpenIR
学科主题药学其他学科
Computational studies on drug-drug interactions and drug-metabolism enzyme interactions
Ma H(马红); Fu T(付婷); Li GH(李国辉)
会议文集Program
会议名称The 4TH Asia-Pacific Regional Meeting of ISSX on Bridging Drug Research to Regulatory Approval
会议日期2010-4-22
2011
会议地点台南
其他题名药物相互作用和药物与代谢酶相互作用的计算机研究
页码0-0
出版者待补充
出版地待补充
合作性质墙报
部门归属1106
主办者台湾成功大学
英文摘要Molecular mechanism of drug-drug interactions and drug-P450 family enzyme interactions are very important for understanding drug metabolism and toxicity, and also guiding drug discovery. The first step for drug-drug interactions and drug-enzyme interactions before their metabolization is the process of drug binding to the metabolism enzyme. This process involves multi-drug binding[1]. Many computational studies have been done to discover different drugs binding to the enzymes but with only one drug molecule involved in the simulation[2, 3]. As lots of experiments have shown that several same and/or different types of drug molecules could bind to the enzyme simultaneously[4, 5]. How does this process happen at atomistic level? Is there time sequencing for different drug molecules binding or not? What is the dynamics behavior of enzyme upon multi-drug binding? Is it different for the enzyme to bind single drug and multi-drug molecules? To uncover these questions, we will adapt two strategies. Firstly, simulated annealing techniques will be used to find the possible initial binding complex structures, and then molecular dynamics will be adapted to relax and finely tune the relative position and orientation of these drug molecules in the binding pocket of enzyme. This two-step modeling procedure will be done many thousands times to find \"good\" binding pose; Second strategy is that multi-copy of drug molecules are included in the molecular dynamics simulation, but the interaction between drug molecules are not calculated at first step, only the interaction involving drug-enzyme and enzyme itself will be computed, at second step the final pose from 1st step will be submitted to the normal molecular dynamics simulation with all the interaction included. Several marketed drugs[6] and p450-3A4 will be selected and tested.; Molecular mechanism of drug-drug interactions and drug-P450 family enzyme interactions are very important for understanding drug metabolism and toxicity, and also guiding drug discovery. The first step for drug-drug interactions and drug-enzyme interactions before their metabolization is the process of drug binding to the metabolism enzyme. This process involves multi-drug binding[1]. Many computational studies have been done to discover different drugs binding to the enzymes but with only one drug molecule involved in the simulation[2, 3]. As lots of experiments have shown that several same and/or different types of drug molecules could bind to the enzyme simultaneously[4, 5]. How does this process happen at atomistic level? Is there time sequencing for different drug molecules binding or not? What is the dynamics behavior of enzyme upon multi-drug binding? Is it different for the enzyme to bind single drug and multi-drug molecules? To uncover these questions, we will adapt two strategies. Firstly, simulated annealing techniques will be used to find the possible initial binding complex structures, and then molecular dynamics will be adapted to relax and finely tune the relative position and orientation of these drug molecules in the binding pocket of enzyme. This two-step modeling procedure will be done many thousands times to find \"good\" binding pose; Second strategy is that multi-copy of drug molecules are included in the molecular dynamics simulation, but the interaction between drug molecules are not calculated at first step, only the interaction involving drug-enzyme and enzyme itself will be computed, at second step the final pose from 1st step will be submitted to the normal molecular dynamics simulation with all the interaction included. Several marketed drugs[6] and p450-3A4 will be selected and tested.
文献类型会议论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/115951
专题中国科学院大连化学物理研究所
通讯作者Li GH(李国辉)
推荐引用方式
GB/T 7714
Ma H,Fu T,Li GH. Computational studies on drug-drug interactions and drug-metabolism enzyme interactions[C]. 待补充:待补充,2011:0-0.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[马红]的文章
[付婷]的文章
[李国辉]的文章
百度学术
百度学术中相似的文章
[马红]的文章
[付婷]的文章
[李国辉]的文章
必应学术
必应学术中相似的文章
[马红]的文章
[付婷]的文章
[李国辉]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。